D009206AnatomyA02.633.580A07.541.704A10.690.552.750361430.916672MyocardiumFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson30284966Swim MM, Albertario A, Iacobazzi D, Caputo M, Ghorbel MTTissue engineering. Part AAmnion-Based Scaffold with Enhanced Strength and Biocompatibility for In Vivo Vascular Repair. Tissue Eng Part A. 2019 04; 25(7-8):603-619.Tissue Eng Part A2018-11-10T00:00:002018Amnion-Based Scaffold with Enhanced Strength and Biocompatibility for In Vivo Vascular Repair.30862451Barefield DY, McNamara JW, Lynch TL, Kuster DWD, Govindan S, Haar L, Wang Y, Taylor EN, Lorenz JN, Nieman ML, Zhu G, Luther PK, Varr? A, Dobrev D, Ai X, Janssen PML, Kass DA, Jones WK, Gilbert RJ, Sadayappan SJournal of molecular and cellular cardiologyAblation of the calpain-targeted site in cardiac myosin binding protein-C is cardioprotective during ischemia-reperfusion injury. J Mol Cell Cardiol. 2019 04; 129:236-246.J Mol Cell Cardiol2019-03-09T00:00:002019Ablation of the calpain-targeted site in cardiac myosin binding protein-C is cardioprotective during ischemia-reperfusion injury.DirkGillespieDirk Gillespie41.87432800000000-87.67059170000000349292Gillespie, DirkProfessorLotharBlatterLothar Blatter41.87432800000000-87.67059170000000349611Blatter, LotharProfessorMichaelFillMichael Fill41.87432800000000-87.67059170000000349613Fill, MichaelProfessorEduardoRiosEduardo Rios41.87432800000000-87.67059170000000349616Rios, EduardoProfessorTomShannonTom Shannon41.87432800000000-87.67059170000000349656Shannon, TomAssociate Professor5Associate Professor4Professor2.506440.0062736136research area of0.8545910.00772918157subject area for32016692Gupta K, Jadhav R, Prasad R, Virmani SJournal of nuclear cardiology : official publication of the American Society of Nuclear CardiologyCardiac uptake patterns in routine 18F-FDG PET-CT scans: A pictorial review. J Nucl Cardiol. 2020 08; 27(4):1296-1305.J Nucl Cardiol2020-02-03T00:00:002020Cardiac uptake patterns in routine 18F-FDG PET-CT scans: A pictorial review.33153533Singh AK, Antiochos P, Singh AT, Kwong RYJACC. Cardiovascular imagingMultiparametric Cardiac Magnetic Resonance for Chronic Kidney Disease: Mapping the Footprints of a "Silent Killer"? JACC Cardiovasc Imaging. 2020 11; 13(11):2368-2370.JACC Cardiovasc Imaging2020-11-01T00:00:002020Multiparametric Cardiac Magnetic Resonance for Chronic Kidney Disease: Mapping the Footprints of a "Silent Killer"?Rush University, Rush Medical College34807265Avolio E, Carrabba M, Milligan R, Kavanagh Williamson M, Beltrami AP, Gupta K, Elvers KT, Gamez M, Foster RR, Gillespie K, Hamilton F, Arnold D, Berger I, Davidson AD, Hill D, Caputo M, Madeddu PClinical science (London, England : 1979)The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease. Clin Sci (Lond). 2021 12 22; 135(24):2667-2689.Clin Sci (Lond)2021-12-22T00:00:002021The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate ProfessorPhysiology and Biophysics